Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Fox

Showing results (11-20 of 127) with videos related to

Pageof 13
Sort By:
Current Drug Targets|September 16, 2010
The mutator phenotype in cancer: molecular mechanisms and targeting strategiesMarc J Prindle, Edward J Fox, Lawrence A Loeb
JBJS Case Connector|December 19, 2017
Arthroscopy-Associated Complications in Osteosarcoma: A Case Report and Review of the LiteratureJohn A Sielatycki, Edward J Fox, Elizabeth E Frauenhoffer
Seminars in Oncology|April 9, 2008
Current surgical management of bone metastases in the extremities and pelvisChristian M Ogilvie, Edward J Fox, Richard D Lackman
Genome Medicine|March 19, 2016
Exploring the implications of distinct mutational signatures and mutation rates in aging and cancerEdward J Fox, Jesse J Salk, Lawrence A Loeb
The Neurologist|December 20, 2007
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologistsEdward J Fox, Timothy K Vartanian, Scott S Zamvil
DNA Repair|August 13, 2010
Reply: Is There Any Genetic Instability in Human Cancer?Edward J Fox, Robert A Beckman, Lawrence A Loeb
Cancer Metastasis Reviews|April 18, 2013
Do mutator mutations fuel tumorigenesis?Edward J Fox, Marc J Prindle, Lawrence A Loeb
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Risks of double-counting in deep sequencingMichael W Schmitt, Edward J Fox, Jesse J Salk
Cancer Research|June 11, 2009
Cancer genome sequencing--an interim analysisEdward J Fox, Jesse J Salk, Lawrence A Loeb
Annual Review of Pathology|September 12, 2009
Mutational heterogeneity in human cancers: origin and consequencesJesse J Salk, Edward J Fox, Lawrence A Loeb
Pageof 13

Showing results (11-20 of 127) with videos related to

Sort By:
Pageof 13
Current Drug Targets|September 16, 2010
The mutator phenotype in cancer: molecular mechanisms and targeting strategiesMarc J Prindle, Edward J Fox, Lawrence A Loeb
JBJS Case Connector|December 19, 2017
Arthroscopy-Associated Complications in Osteosarcoma: A Case Report and Review of the LiteratureJohn A Sielatycki, Edward J Fox, Elizabeth E Frauenhoffer
Seminars in Oncology|April 9, 2008
Current surgical management of bone metastases in the extremities and pelvisChristian M Ogilvie, Edward J Fox, Richard D Lackman
Genome Medicine|March 19, 2016
Exploring the implications of distinct mutational signatures and mutation rates in aging and cancerEdward J Fox, Jesse J Salk, Lawrence A Loeb
The Neurologist|December 20, 2007
The immunogenicity of disease-modifying therapies for multiple sclerosis: clinical implications for neurologistsEdward J Fox, Timothy K Vartanian, Scott S Zamvil
DNA Repair|August 13, 2010
Reply: Is There Any Genetic Instability in Human Cancer?Edward J Fox, Robert A Beckman, Lawrence A Loeb
Cancer Metastasis Reviews|April 18, 2013
Do mutator mutations fuel tumorigenesis?Edward J Fox, Marc J Prindle, Lawrence A Loeb
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Risks of double-counting in deep sequencingMichael W Schmitt, Edward J Fox, Jesse J Salk
Cancer Research|June 11, 2009
Cancer genome sequencing--an interim analysisEdward J Fox, Jesse J Salk, Lawrence A Loeb
Annual Review of Pathology|September 12, 2009
Mutational heterogeneity in human cancers: origin and consequencesJesse J Salk, Edward J Fox, Lawrence A Loeb
Pageof 13